U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07856823) titled 'High-Resolution Measurements of Diet-Microbiome Interactions' on Sept. 28.
Brief Summary: The goal of this clinical trial is to characterize regional intestinal fermentation physiology and determine how the response to fermentable dietary fiber differs between healthy individuals and individuals with irritable bowel syndrome (IBS). The study will use ingestible capsule technologies to directly measure intestinal gases and regional microbiome composition following low-fiber and high-fiber meal challenges.
The main questions it aims to answer are:
Does the change in regional intestinal gas levels following a fermentable-fiber challen...